Ferric derisomaltose - Generic Drug Details
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What are the generic sources for ferric derisomaltose and what is the scope of patent protection?
Ferric derisomaltose
is the generic ingredient in one branded drug marketed by Pharmacosmos As and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.Ferric derisomaltose has forty-one patent family members in twenty-five countries.
One supplier is listed for this compound.
Summary for ferric derisomaltose
| International Patents: | 41 |
| US Patents: | 2 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 4 |
| Clinical Trials: | 17 |
| Patent Applications: | 8 |
| What excipients (inactive ingredients) are in ferric derisomaltose? | ferric derisomaltose excipients list |
| DailyMed Link: | ferric derisomaltose at DailyMed |
Recent Clinical Trials for ferric derisomaltose
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alberta Health Services, Calgary | Phase 3 |
| AHS Cancer Control Alberta | Phase 3 |
| University of Michigan | Phase 3 |
US Patents and Regulatory Information for ferric derisomaltose
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-002 | Jan 16, 2020 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-001 | Jan 16, 2020 | DISCN | Yes | No | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| Pharmacosmos As | MONOFERRIC | ferric derisomaltose | SOLUTION;INTRAVENOUS | 208171-003 | Jan 16, 2020 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | Y | See Plans and Pricing | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for ferric derisomaltose
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Denmark | 2411053 | See Plans and Pricing | |
| Spain | 2617658 | See Plans and Pricing | |
| Hong Kong | 1164138 | 穩定的鐵寡糖複合物 (A STABLE IRON OLIGOSACCHARIDE COMPOUND) | See Plans and Pricing |
| Canada | 2756580 | COMPOSE OLIGOSACCHARIDE STABLE ASSOCIE AU FER (A STABLE IRON OLIGOSACCHARIDE COMPOUND) | See Plans and Pricing |
| European Patent Office | 2411053 | COMPOSÉ OLIGOSACCHARIDE STABLE ASSOCIÉ AU FER (A STABLE IRON OLIGOSACCHARIDE COMPOUND) | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ferric derisomaltose
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2411053 | C02411053/01 | Switzerland | See Plans and Pricing | PRODUCT NAME: FERRUM (III) UT FERRI ISOMALTOSIDUM; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 67001 26.08.2019 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
